Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 286493, 5 pages
http://dx.doi.org/10.1155/2014/286493
Review Article

Clinical Applications of Procalcitonin in Pediatrics: An Advanced Biomarker for Inflammation and Infection—Can It Also Be Used in Trauma?

1Department of Pediatrics, St. Christopher’s Hospital for Children, 3601 A Street, Philadelphia, PA 19134, USA
2Drexel University College of Medicine, Philadelphia, PA, USA
3Department of Neonatology, St. Christopher’s Hospital for Children, Philadelphia, PA, USA
4First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece

Received 3 June 2014; Accepted 30 September 2014; Published 29 October 2014

Academic Editor: Raffaele Pezzilli

Copyright © 2014 Ioannis Koutroulis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Maier, S. Wutzler, M. Lehnert et al., “Serum procalcitonin levels in patients with multiple injuries including visceral trauma,” Journal of Trauma—Injury, Infection and Critical Care, vol. 66, no. 1, pp. 243–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Reinhart, M. Bauer, N. C. Riedemann, and C. S. Hartog, “New approaches to sepsis: Molecular diagnostics and biomarkers,” Clinical Microbiology Reviews, vol. 25, no. 4, pp. 609–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. N. Gilbert, “Use of plasma procalcitonin levels as an adjunct to clinical microbiology,” Journal of Clinical Microbiology, vol. 48, no. 7, pp. 2325–2329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. V. K. Patil, J. B. Morjaria, F. D. Villers, and S. K. Babu, “Associations between procalcitonin and markers of bacterial sepsis,” Medicina, vol. 48, no. 8, pp. 383–387, 2012. View at Google Scholar · View at Scopus
  5. G. A. Wanner, M. Keel, U. Steckholzer, W. Beier, R. Stocker, and W. Ertel, “Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients,” Critical Care Medicine, vol. 28, no. 4, pp. 950–957, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Foushee, N. H. Hope, and E. E. Grace, “Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 11, pp. 2560–2569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Marshall and K. Reinhart, “Biomarkers of sepsis,” Critical Care Medicine, vol. 37, no. 7, pp. 2290–2298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Wheeler, H. R. Wong, and B. Zingarelli, “Pediatric sepsis—part I, children are not small adults!,” Open Inflammation Journal, vol. 7, no. 4, pp. 4–15, 2011. View at Google Scholar
  9. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon, “High serum procalcitonin concentrations in patients with sepsis and infection,” The Lancet, vol. 341, no. 8844, pp. 515–518, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Rey, M. Los Arcos, A. Concha et al., “Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children,” Intensive Care Medicine, vol. 33, no. 3, pp. 477–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Casado-Flores, A. Blanco-Quirós, J. Asensio, E. Arranz, J. A. Garrote, and M. Nieto, “Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count,” Pediatric Critical Care Medicine, vol. 4, no. 2, pp. 190–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Isidor, G. Caillaux, V. Gilquin et al., “The use of procalcitonin in the diagnosis of late-onset infection in neonatal intensive care unit patients,” Scandinavian Journal of Infectious Diseases, vol. 39, no. 11-12, pp. 1063–1066, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Cies and A. Chopra, “Procalcitonin use in a pediatric intensive care unit,” Pediatric Infectious Disease Journal, vol. 33, no. 9, pp. 984–986, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Simon, P. Saint-Louis, D. K. Amre, J. Lacroix, and F. Gauvin, “Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome,” Pediatric Critical Care Medicine, vol. 9, no. 4, pp. 407–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Wacker, A. Prkno, F. M. Brunkhorst, and P. Schlattmann, “Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 13, no. 5, pp. 426–435, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. J. Shields, R. D. Comstock, S. A. Fernandez, H. Xiang, and G. A. Smith, “Healthcare resource utilization and epidemiology of pediatric burn-associated hospitalizations, United States, 2000,” Journal of Burn Care and Research, vol. 28, no. 6, pp. 811–826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Greenhalgh, J. R. Saffle, J. H. Holmes et al., “American burn association consensus conference to define sepsis and infection in burns,” Journal of Burn Care and Research, vol. 28, no. 6, pp. 776–790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Mann, G. L. Wood, and C. E. Wade, “Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature,” Burns, vol. 37, no. 4, pp. 549–558, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. M. Abdel-Hafez, Y. Saleh Hassan, and T. H. El-Metwally, “A study on biomarkers, cytokines, and growth factors in children with burn injuries,” Annals of Burns and Fire Disasters, vol. 20, no. 2, pp. 89–100, 2007. View at Google Scholar
  20. A. N. Neely, L. A. Fowler, R. J. Kagan, and G. D. Warden, “Procalcitonin in pediatric burn Patients: an early indicator of sepsis?” Journal of Burn Care and Rehabilitation, vol. 25, no. 1, pp. 76–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. H. S. Kim, H. T. Yang, J. Hur et al., “Procalcitonin levels within 48 hours after burn injury as a prognostic factor,” Annals of Clinical and Laboratory Science, vol. 42, no. 1, pp. 57–64, 2012. View at Google Scholar · View at Scopus
  22. M. Meisner, H. Adina, and J. Schmidt, “Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients,” Critical Care, vol. 10, no. 1, article R1, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. P. Castelli, C. Pognani, M. Cita, and R. Paladini, “Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma,” Critical Care Medicine, vol. 37, no. 6, pp. 1845–1849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. F. Liu, X. M. Tong, F. Y. Zheng, M. H. Piao, and Y. Z. Ning, “Physiological changes in serum procalcitonin concentrations in premature infants early after birth,” Chinese Journal of Contemporary Pediatrics, vol. 15, no. 2, pp. 81–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. V. Sakran, C. P. Michetti, M. J. Sheridan et al., “The utility of procalcitonin in critically ill trauma patients,” Journal of Trauma and Acute Care Surgery, vol. 73, no. 2, pp. 413–418, 2012. View at Publisher · View at Google Scholar · View at Scopus